Medicine – Paget’s Disease of Bone

Paget’s disease of bone, also called osteitis deformans, is a chronic disorder of bone remodelling characterised by markedly increased and disorganised bone turnover.

There is initially excessive osteoclastic bone resorption, followed by excessive but poorly organised osteoblastic new bone formation. The newly formed bone is therefore enlarged and dense in places, but its architecture is abnormal and mechanically weaker than normal bone.

The characteristic biochemical finding is:

Markedly raised alkaline phosphatase – ALP ↑↑

with usually:

Normal calcium and normal phosphate.

1. Normal Bone Remodelling

Normal bone undergoes continuous remodelling through coordinated activity between:

Osteoclasts – resorb old bone

and

Osteoblasts – form new bone.

Normally these processes are tightly coupled, allowing old or damaged bone to be replaced by structurally organised new bone.

In Paget’s disease, this process becomes:

Excessive + accelerated + disorganised.

2. Pathophysiology

The disease typically begins with excessive:

Osteoclastic bone resorption.

This is followed by a compensatory increase in:

Osteoblastic bone formation.

However, the new bone is deposited rapidly and in a disorganised fashion.

Therefore:

↑ Osteoclast activity

↓

Excessive bone resorption

↓

Compensatory ↑↑ osteoblast activity

↓

Rapid abnormal bone formation

↓

Enlarged, architecturally disorganised and mechanically abnormal bone.

3. Mosaic Pattern of Bone

Normal mature lamellar bone has an organised architecture.

In Paget’s disease, repeated cycles of abnormal resorption and formation produce irregular cement lines.

Histologically this produces the characteristic:

Mosaic pattern of lamellar bone.

This is an important pathological feature of Paget’s disease.

4. Distribution of Disease

Paget’s disease may involve:

One bone – monostotic disease

or:

Multiple bones – polyostotic disease.

However, the disease does not normally spread directly from one bone to another.

Each affected skeletal site represents a separate focus.

5. Commonly Affected Bones

Common sites include:

Pelvis.

Femur.

Lumbar spine.

Skull.

Tibia.

These locations help explain many of the characteristic complications.

6. Age

Paget’s disease is predominantly a disorder of:

Older adults.

It is uncommon in young people, and prevalence rises considerably with:

Increasing age.

Many patients are diagnosed incidentally when an elevated ALP or characteristic radiographic abnormality is discovered.

7. Clinical Presentation

A very important point is that many patients with Paget’s disease are:

Asymptomatic.

The disease may be discovered because of:

Incidentally elevated ALP

or

An abnormal X-ray obtained for another reason.

When symptoms occur, the original notes correctly identify:

Bone pain.

Bone deformity.

Secondary arthritis.

Nerve compression.

Pathological fractures.

Rarely:

Sarcomatous transformation.

8. Bone Pain

The most common symptomatic presentation is:

Bone pain.

The pain may be:

Deep.

Aching.

Persistent.

It may arise from increased bone turnover itself or from complications such as:

Microfractures, deformity or secondary osteoarthritis.

9. Bone Deformity

Because Pagetic bone is remodelled abnormally, affected bones may become:

Enlarged.

Thickened.

Bowed.

Deformed.

Weight-bearing long bones are particularly susceptible to deformity.

10. Bowing of the Tibia or Femur

Paget’s disease involving the lower limbs may cause:

Bowing of the tibia

or

Bowing of the femur.

This alters mechanical loading across nearby joints and can contribute to:

Pain and secondary osteoarthritis.

11. Skull Involvement

Paget’s disease of the skull can cause progressive:

Skull enlargement and thickening.

Historically, patients may report that:

Their hat size has increased.

Skull involvement can also produce:

Headache

and important neurological complications.

12. Hearing Loss

A particularly important complication of skull involvement is:

Hearing impairment.

Changes in the temporal bone and structures surrounding the auditory apparatus can interfere with normal hearing.

Therefore:

PAGET’S DISEASE + ENLARGED SKULL + HEARING LOSS

is a classic clinical association.

13. Secondary Osteoarthritis

The original notes correctly include:

Arthritis.

More precisely, Paget’s disease can cause:

Secondary osteoarthritis.

Deformed bone changes the normal alignment and mechanical loading of adjacent joints.

This accelerates:

Degenerative joint disease.

Commonly affected areas may include the:

Hip

and

Knee.

14. Nerve Compression

The original notes correctly include:

Nerve compression.

Pagetic bone may enlarge sufficiently to compress nearby:

Nerves

or other neural structures.

This is particularly relevant when disease affects the:

Skull

or

Spine.

15. Neurological Complications

Depending on the affected site, neurological complications can include:

Hearing loss.

Radiculopathy.

Spinal stenosis.

Spinal cord or nerve-root compression.

Other cranial neuropathies are possible but less common.

Therefore new neurological symptoms in a patient with Paget’s disease require appropriate assessment.

16. Pathological Fractures

The original notes correctly include:

Fractures.

Although Pagetic bone can become enlarged and radiographically dense, it is:

Structurally abnormal and mechanically weaker.

Therefore affected bones are more susceptible to:

Pathological or insufficiency fractures.

17. Femoral Fractures

Long bones affected by Paget’s disease may develop:

Fissure fractures

and complete fractures.

The:

Femur

is particularly important because deformity and abnormal mechanical stress may coexist.

18. Sarcomatous Transformation

The original notes correctly include:

Sarcoma.

Malignant transformation is a:

Rare but serious complication.

The classic malignancy is:

Osteosarcoma.

Other bone sarcomas may occur less commonly.

19. When to Suspect Sarcomatous Transformation

Concerning features include:

New or rapidly worsening bone pain.

Increasing swelling or mass.

Rapidly progressive destructive radiographic change.

Such features require urgent investigation.

However, malignant transformation occurs in only a:

Small minority of patients.

Therefore Paget’s disease should not be regarded as routinely premalignant.

20. High-Output Cardiac Failure

Extensive Paget’s disease can produce increased:

Bone vascularity.

In very extensive disease, blood flow through affected bone can increase substantially.

Rarely, this may contribute to:

High-output cardiac failure.

This is an uncommon complication but a classic examination association.

21. Alkaline Phosphatase

The most characteristic biochemical abnormality is:

ALP ↑↑.

This reflects the marked increase in:

Osteoblastic activity and bone formation.

Therefore an older patient with:

Markedly raised ALP

but:

Normal calcium and phosphate

should raise suspicion for Paget’s disease, particularly when liver disease has been excluded.

22. Why ALP Is Raised

After excessive osteoclastic resorption, osteoblasts become highly active in attempting to rebuild bone.

Osteoblasts produce:

Bone-specific alkaline phosphatase.

Therefore:

↑↑ bone formation → ↑↑ ALP.

The magnitude of ALP elevation often broadly reflects the:

Extent and activity of disease.

23. Calcium

The original notes correctly emphasise that calcium is generally:

Normal.

Despite extensive bone turnover, systemic calcium homeostasis is usually maintained.

Therefore the classic pattern is:

Ca²⁺ = normal.

24. Hypercalcaemia and Immobilisation

The traditional teaching that calcium becomes raised during:

Immobilisation

is reasonable but needs qualification.

Hypercalcaemia is not a routine feature of Paget’s disease.

It may occasionally develop in a patient with active Paget’s disease who becomes substantially immobilised because bone resorption continues while mechanical loading falls.

However, if hypercalcaemia is found, clinicians should also investigate other causes such as:

Primary hyperparathyroidism or malignancy.

25. Phosphate

Serum phosphate is usually:

Normal.

Therefore the classic biochemical pattern is:

Ca²⁺ normal

PO₄³⁻ normal

ALP ↑↑

PTH usually normal.

This pattern is extremely useful for examinations.

26. PTH

PTH is usually:

Normal.

This distinguishes Paget’s disease from disorders such as:

Primary hyperparathyroidism

and

Secondary hyperparathyroidism due to CKD or vitamin D deficiency.

27. Liver Versus Bone ALP

An isolated elevation of total ALP does not automatically indicate bone disease because ALP is also produced by:

Liver and biliary tissue.

Therefore if the source is uncertain, clinicians may use:

Liver biochemical tests

and sometimes:

Bone-specific ALP.

If ALP is markedly elevated while other liver markers do not suggest cholestatic disease, a bone source becomes more likely.

28. Diagnosis

The original notes correctly state that diagnosis is based on:

Clinical features

plus characteristic:

Radiographs

and, when appropriate:

Bone scintigraphy.

Biochemistry helps identify active disease but does not by itself establish the complete anatomical extent.

29. Plain Radiographs

Affected bones may show a mixture of:

Osteolysis

and

Sclerosis.

This reflects the different phases of abnormal remodelling.

Other features include:

Cortical thickening.

Bone enlargement.

Coarsened trabeculae.

Deformity.

30. Skull X-Ray

Skull involvement can produce patchy areas of sclerosis.

The classic descriptive appearance is:

“Cotton-wool” skull.

This results from irregular areas of increased bone density.

31. Long-Bone Radiographic Changes

Long bones may demonstrate:

Cortical thickening.

Trabecular coarsening.

Bone enlargement.

Bowing deformity.

Early active osteolysis may advance along a long bone as a characteristic:

Blade-of-grass or flame-shaped advancing edge.

32. Bone Scan

A radionuclide:

Bone scan

is particularly useful for determining:

The distribution and extent of active Paget’s disease.

Affected areas demonstrate:

Increased tracer uptake

because of the high rate of bone turnover.

Therefore:

X-ray → characterises the lesion.

Bone scan → maps the extent of active skeletal involvement.

33. Bone Biopsy

Bone biopsy is:

Not routinely required

when the biochemical and radiological findings are typical.

It may be considered if the diagnosis is uncertain or there is concern about:

Malignant transformation.

34. Treatment Principles

Not every patient with Paget’s disease requires active pharmacological treatment.

Treatment is particularly considered when disease is:

Symptomatic

or when active disease involves sites where complications are a significant concern.

The major treatment goals are:

Relieve bone pain.

Suppress excessive bone turnover.

Treat or prevent complications when possible.

35. Analgesia

The original notes correctly include:

Analgesia.

Pain management depends on its cause.

Simple analgesics may help, while pain from:

Secondary osteoarthritis

may require additional musculoskeletal management.

However, pain directly attributable to metabolically active Paget’s disease may improve when bone turnover is suppressed with:

Bisphosphonate therapy.

36. Bisphosphonates

The original notes correctly identify:

Bisphosphonates

as the major pharmacological treatment.

Bisphosphonates inhibit:

Osteoclast-mediated bone resorption.

This suppresses the abnormal remodelling cycle.

Therefore:

↓ Osteoclast activity

↓

↓ Excessive bone turnover

↓

↓ ALP

↓

Improvement in disease activity and often:

Bone pain.

37. Zoledronic Acid

A particularly effective treatment is:

Intravenous zoledronic acid.

A single infusion can produce a prolonged biochemical remission in many appropriately selected patients.

Renal function, calcium and vitamin D status need consideration before bisphosphonate therapy.

38. Monitoring Treatment

Treatment response can be followed using:

Serum ALP.

As disease activity falls:

ALP generally decreases.

Therefore ALP is useful both for:

Initial assessment of activity

and

Monitoring biochemical response to treatment.

39. Calcium and Vitamin D

Adequate:

Calcium

and

Vitamin D

status is important, particularly around potent bisphosphonate treatment.

Vitamin D deficiency should be identified and corrected where appropriate because potent inhibition of bone resorption can otherwise increase the risk of:

Hypocalcaemia.

40. Orthopaedic Treatment

Some complications require:

Orthopaedic management.

Examples include:

Pathological fractures.

Severe deformity.

Advanced secondary osteoarthritis requiring joint replacement.

Neurological compression may occasionally require specialist surgical assessment.

41. Paget’s Disease – Clinical Features in Note Form

BONE PAIN

Deep aching pain from active disease or complications.

BONE DEFORMITY

Enlarged and bowed bones.

Increasing skull size.

Bowing of long bones.

SECONDARY OSTEOARTHRITIS

Abnormal bone alignment alters joint mechanics.

Commonly affects joints adjacent to Pagetic bone.

NERVE COMPRESSION

Hearing impairment.

Radiculopathy.

Spinal stenosis.

Other neurological compression depending on site.

FRACTURES

Abnormally remodelled bone is mechanically weak.

Pathological/insufficiency fractures may occur.

SARCOMA

Rare malignant transformation.

Classically:

Osteosarcoma.

HIGH-OUTPUT HEART FAILURE

Rare.

May occur with very extensive, highly vascular disease.

42. Biochemistry – Note Form

ALP:

↑↑

The characteristic biochemical abnormality.

Calcium:

Usually:

Normal.

May rarely rise with substantial immobilisation, but hypercalcaemia should prompt consideration of additional causes.

Phosphate:

Usually:

Normal.

PTH:

Usually:

Normal.

Therefore:

PAGET = NORMAL Ca²⁺ + NORMAL PO₄³⁻ + MARKEDLY HIGH ALP.

43. Diagnosis – Note Form

Clinical presentation:

Often asymptomatic.

May have bone pain, deformity or complications.

Blood tests:

Markedly elevated ALP.

Usually normal calcium and phosphate.

Plain X-ray:

Mixed lytic and sclerotic changes.

Cortical thickening.

Coarse trabeculae.

Bone enlargement.

Deformity.

Cotton-wool skull.

Blade-of-grass/flame-shaped advancing osteolysis in long bones.

Bone scan:

Increased uptake in active lesions.

Useful for determining:

Extent of skeletal involvement.

44. Treatment – Note Form

ANALGESIA

For symptomatic pain.

BISPHOSPHONATES

Main disease-suppressing therapy.

Particularly:

IV zoledronic acid in appropriate patients.

CALCIUM/VITAMIN D

Ensure adequate status, especially around potent bisphosphonate treatment.

ORTHOPAEDIC/SPECIALIST MANAGEMENT

For fractures.

Severe deformity.

Advanced osteoarthritis.

Neurological compression.

Suspected sarcomatous transformation.

45. Paget’s Disease Versus Osteoporosis

PAGET’S DISEASE:

Bone turnover:

Markedly increased and disorganised.

ALP:

↑↑

Calcium:

Normal.

Phosphate:

Normal.

Bone may be:

Enlarged and deformed.

OSTEOPOROSIS:

Bone mass:

Reduced.

Bone mineralisation:

Normal.

ALP:

Normal.

Calcium:

Normal.

Phosphate:

Normal.

Main consequence:

Fragility fractures.

46. Paget’s Disease Versus Osteomalacia

PAGET’S DISEASE:

Ca²⁺:

Normal.

PO₄³⁻:

Normal.

ALP:

↑↑

PTH:

Usually normal.

VITAMIN D DEFICIENCY OSTEOMALACIA:

Ca²⁺:

Low or low-normal.

PO₄³⁻:

Low.

ALP:

↑.

PTH:

↑.

Therefore:

NORMAL Ca + NORMAL PO₄ + VERY HIGH ALP → THINK PAGET’S DISEASE.

47. Important Clarifications to the Original Notes

The statement:

“Increased bone turnover with abnormal new bone turnover”

is better expressed as:

EXCESSIVE OSTEOCLASTIC RESORPTION FOLLOWED BY EXCESSIVE, DISORGANISED OSTEOBLASTIC NEW BONE FORMATION.

The original:

“↑↑ ALP”

is a particularly important and correct examination finding.

Remember:

ALP ↑↑ while Ca²⁺ and phosphate are usually normal.

The statement:

“Calcium raised only with immobility”

should be softened.

Serum calcium is:

Usually normal.

Hypercalcaemia can occasionally occur during significant immobilisation in active disease, but if calcium is elevated, other causes should also be considered.

The original diagnostic approach is correct:

Characteristic radiographs establish the structural pattern, while a bone scan helps determine the extent of active disease.

The original treatment principle is also correct:

Analgesia + bisphosphonates.

For metabolically active symptomatic disease requiring anti-Pagetic therapy, a potent bisphosphonate such as:

Zoledronic acid

is an important modern option.

Key Clinical Pattern

For rapid recall:

PAGET’S DISEASE = EXCESSIVE + DISORGANISED BONE REMODELLING.

The sequence is:

↑ OSTEOCLAST ACTIVITY

↓

↑ BONE RESORPTION

↓

↑↑ COMPENSATORY OSTEOBLAST ACTIVITY

↓

DISORGANISED NEW BONE

↓

ENLARGED BUT MECHANICALLY ABNORMAL BONE.

The classic biochemical pattern is:

Ca²⁺ = NORMAL

PO₄³⁻ = NORMAL

ALP = ↑↑

PTH = NORMAL.

The classic clinical features are:

BONE PAIN + DEFORMITY + SECONDARY ARTHRITIS + HEARING/NEURAL COMPRESSION + FRACTURES.

Rarely:

OSTEOSARCOMA.

The classic investigation clues are:

↑↑ ALP + COTTON-WOOL SKULL + COARSE/THICKENED ABNORMAL BONE + INCREASED UPTAKE ON BONE SCAN.

And the major disease-suppressing treatment is:

BISPHOSPHONATE THERAPY, particularly zoledronic acid when appropriate.